Published in Endoscopy on May 01, 2004
Endoscopic management of pancreatic pseudocysts at atypical locations. Surg Endosc (2009) 1.39
Mediastinal pancreatic pseudocyst--a case report and review of the literature. MedGenMed (2007) 1.35
Endoscopic ultrasound-guided drainage of a cystic metastasis in the mediastinum that caused tracheal obstruction. Endoscopy (2005) 1.12
Mediastinal pancreatic pseudocyst with isolated thoracic symptoms: a case report. J Med Case Rep (2008) 1.00
Endoscopic ultrasound-guided transesophageal drainage of a mediastinal pancreatic pseudocyst. Endoscopy (2006) 0.92
Mediastinal extension of a complicated pancreatic pseudocyst; a case report and literature review. J Med Case Rep (2007) 0.90
Pancreatic pseudocyst presenting as dysphagia: a case report. Saudi J Gastroenterol (2008) 0.80
Endotherapy for complications of pancreatitis: ready for prime time. Clin Med Res (2004) 0.75
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther (2014) 3.91
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun (1989) 2.60
An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature (1994) 2.57
Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect (2001) 2.50
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat (2011) 2.30
Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology (1999) 2.20
Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther (2014) 2.18
[Intra-arterial calcium provocation for the preoperative diagnosis of the location of an occult insulinoma]. Dtsch Med Wochenschr (1992) 2.02
[Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity]. Z Gastroenterol (2014) 2.02
Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol (2000) 1.85
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa. Microbiology (2000) 1.66
Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology (2000) 1.64
Anionic phospholipids are involved in membrane association of FtsY and stimulate its GTPase activity. EMBO J (2000) 1.56
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol (1999) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Chaotropic anions and the surface potential of bilayer membranes. Biochim Biophys Acta (1975) 1.48
Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther (2012) 1.47
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol (2011) 1.45
Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion (1997) 1.42
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs. J Viral Hepat (2012) 1.42
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol (2001) 1.42
Lymphangioma of the pancreas and the duodenal wall: MR imaging findings. Eur Radiol (2001) 1.37
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat (2013) 1.37
Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis. Aliment Pharmacol Ther (2008) 1.36
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy. Aliment Pharmacol Ther (2010) 1.36
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem (1996) 1.31
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol (2006) 1.29
Retroperitoneal endoscopic debridement for infected peripancreatic necrosis. Lancet (2000) 1.26
Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology (1994) 1.25
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage (2008) 1.24
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut (2003) 1.24
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I. Clin J Pain (2001) 1.21
[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol (2008) 1.19
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat (2011) 1.18
Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell lines. Virus Res (1997) 1.18
Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax (2009) 1.17
Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology (1992) 1.17
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Hepatitis C virus kinetics. Antivir Ther (2000) 1.15
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med (2001) 1.15
Review article: predicting response in hepatitis C virus therapy. Aliment Pharmacol Ther (2006) 1.15
Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl (1999) 1.14
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Ann Oncol (2007) 1.12
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology (1997) 1.11
An indirect ELISA for the detection of antibodies against porcine reproductive and respiratory syndrome virus using recombinant nucleocapsid protein as antigen. J Virol Methods (1997) 1.11
[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol (2011) 1.11
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology (2000) 1.10
Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture. J Virol (1998) 1.10
Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut (2002) 1.09
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol (1996) 1.09
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat (2007) 1.07
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia (2012) 1.06
Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther (2012) 1.05
Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res (2002) 1.05
5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut (2000) 1.04
Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. J Hepatol (1997) 1.04
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b. J Viral Hepat (2011) 1.03
Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Dermatology (1997) 1.03
Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun (1996) 1.03
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha. Eur J Clin Invest (2000) 1.03
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol (1998) 1.03
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies. J Viral Hepat (2014) 1.02
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther (2005) 1.02
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer. Z Gastroenterol (2002) 1.01
Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther (2007) 1.01
Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol (1996) 1.00
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J Viral Hepat (2005) 0.99
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther (2005) 0.99
Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia (2004) 0.99
Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors. Curr Pharm Des (2004) 0.98
Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother (1997) 0.98
Basement membrane components are potent promoters of rat intestinal epithelial cell differentiation in vitro. Gastroenterology (1990) 0.98
X-ray crystal structure of ferric Aplysia limacina myoglobin in different liganded states. J Mol Biol (1993) 0.98
A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation. Am J Gastroenterol (2001) 0.98
Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV--a feasibility study. Eur Radiol (2008) 0.98
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol (2000) 0.97
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis (2011) 0.97
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response. J Infect Dis (2000) 0.96
Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression. J Viral Hepat (2004) 0.96
Littoral cell angioma of the spleen: CT and MR imaging appearance. Eur Radiol (2000) 0.96
Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut (1993) 0.95
Use of preoperative vascular embolisation in spinal metastasis resection. Arch Orthop Trauma Surg (1997) 0.95
Interaction of caffeine-, IP3- and vanadate-sensitive Ca2+ pools in acinar cells of the exocrine pancreas. J Membr Biol (1991) 0.95
Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am J Pathol (1999) 0.94
Pathophysiological changes after traumatic brain injury: comparison of two experimental animal models by means of MRI. MAGMA (2002) 0.94
Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. Anal Biochem (1995) 0.94
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease. Ultraschall Med (2009) 0.94
Groove pancreatitis: an important differential diagnosis to malignant stenosis of the duodenum. Dig Dis Sci (2001) 0.94
Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med (2001) 0.94